Results 1 to 10 of about 51,923 (190)
Relationship Between Bronchodilator Reversibility and Spirometry Response to Dupilumab in Type 2 High Uncontrolled Severe Asthma. [PDF]
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 253-255, March 2025.
Greig R+4 more
europepmc +2 more sources
Bronchodilators for bronchiolitis [PDF]
Bronchiolitis is an acute, viral lower respiratory tract infection affecting infants and often treated with bronchodilators.To assess the effects of bronchodilators on clinical outcomes in infants with acute bronchiolitis.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 1) which contains the ...
Melissa B Scribani, Anne Gadomski
openaire +5 more sources
The future of bronchodilation: looking for new classes of bronchodilators [PDF]
Available bronchodilators can satisfy many of the needs of patients suffering from airway disorders, but they often do not relieve symptoms and their long-term use raises safety concerns. Therefore, there is interest in developing new classes that could help to overcome the limits that characterise the existing classes.At least nine potential new ...
Cazzola, Mario+2 more
openaire +5 more sources
Testing bronchodilator responsiveness [PDF]
Neither flow-related nor volume-related bronchodilator reversibility were independently associated with the symptom burden, health status or dyspnoea in the COPD populationhttp://bit.ly ...
Judith Garcia-Aymerich+12 more
openaire +9 more sources
COPD: maximization of bronchodilation [PDF]
The most recent guidelines define COPD in a multidimensional way, nevertheless the diagnosis is still linked to the limitation of airflow, usually measured by the reduction in the FEV1/FVC ratio below 70%. However, the severity of obstruction is not directly correlated to symptoms or to invalidity determined by COPD.
Stefano Nardini+9 more
openaire +7 more sources
ABSTRACT Background Type 2 inflammation dominates eosinophilic chronic rhinosinusitis (eCRS) and adult onset asthma. IL‐4, ‐5, and ‐13 are prominent disease mediators. Disease control can be achieved with biologic therapies. However, despite some patients entering remission, others experience poor control. Aim We aimed to describe eCRS patients treated
Peta‐Lee Sacks+8 more
wiley +1 more source
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves+3 more
wiley +1 more source
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He+16 more
wiley +1 more source
In the study of V. sebifera plant organs, the leaves exhibited the highest EO content, with peak production in February, the Amazonian winter. Notably, among the various plant parts yielding EO, the fruit peel contained the highest oil concentration. ABSTRACT The essential oils (EOs) of Virola sebifera were obtained from leaves, seed fruits and husked ...
Jorddy Neves Cruz+5 more
wiley +1 more source
Clinical progress note: Pertussis
Abstract Pertussis, commonly known as whooping cough, is a vaccine‐preventable respiratory disease with rising incidence due to declining vaccination rates and waning immunity. The most severe disease course is seen in unvaccinated or incompletely vaccinated infants less than 2 months of age, accounting for the largest burden of hospitalization and ...
Samantha Hanna, Nicole Samies
wiley +1 more source